Sponsored Webinar: Risk Stratification of Patients with Suspected Meningitis and/or Respiratory Infections in the ED
Sponsored by bioMérieux
Being able to quickly differentiate a bacterial from a viral infection without negatively impacting patient outcomes is imperative for healthcare professionals, and it has become even more crucial during the COVID-19 pandemic. In this sponsored webinar, learn how syndromic testing and procalcitonin (PCT) can be used to reduce unnecessary admissions, improve etiological diagnoses, and reduce suboptimal antibiotic therapies in patients presenting to the ED.
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
At the end of the activity, the learner will be able to:
- Understand the tools available to quickly differentiate a viral from a bacterial infection;
- Learn to make a more informed admit/no admit decision based on the causative pathogen;
- Determine the right tests to help minimize time on inappropriate or unnecessary therapy in patients.
Sepsis Alliance gratefully acknowledges the support provided for this webinar by bioMérieux.
Rodrigo Hasbun, MD, MPH, FIDSA
Professor, Infectious Diseases, UTHealth Houston, McGovern Medical School
Rodrigo Hasbun, M.D., M.P.H., is Professor of Medicine; he obtained his medical degree at the Autonomous University of Central America in San Jose, Costa Rica in 1991. He completed his internal medicine residency at the University of Texas Medical Branch in Galveston in 1994 and then went to Yale University for five years for a fellowship in Infectious Diseases and Clinical Research by obtaining a National Research Service Award grant and by enrolling in the Robert Wood Johnson Clinical Scholars Program. During this time, he conducted studies in meningitis and endocarditis that have been incorporated into national guidelines. In 1999, he joined Tulane University in New Orleans where he obtained an MPH in Clinical Research and received an NIH K23 training grant to study adults with the aseptic meningoencephalitis syndrome. He joined the McGovern Medical School at UTHealth in September 2008 and has validated and expanded his meningoencephalitis study to multiple centers and to the pediatric population. In collaboration with pediatrics, he has received support from the Grant A Starr Foundation since 2010 to help advance the management of adults and children with meningitis and encephalitis and is evaluating novel technologies (such as multiplex PCR and next generation sequencing) to improve the diagnostic field.
No continuing education credits are offered for the Sponsor Innovation Webinar.
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare provider. Sepsis Alliance recommends users consult their physician or healthcare provider regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.